Björn Pasternak

Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study

Peter Ueda, Henrik Svanström, Mads Melbye et al. · BMJ · 2018 · 367 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Risk of major congenital malformations in relation to maternal overweight and obesity severity: cohort study of 1.2 million singletons

Martina Persson, Sven Cnattingius, Eduardo Villamor et al. · BMJ · 2017 · 303 citations · Full text

Public Health, Maternal Health, Obstetrics +16

Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study

Lisen Arnheim‐Dahlström, Björn Pasternak, Henrik Svanström et al. · BMJ · 2013 · 273 citations · Full text

Medicine, Radiology, Surgery +15

Association Between Tumor Necrosis Factor-α Antagonists and Risk of Cancer in Patients With Inflammatory Bowel Disease

Nynne Nyboe Andersen, Björn Pasternak, Saima Basit et al. · JAMA · 2014 · 268 citations

Medicine, Oncology, Pharmacology +14

Fluoroquinolone use and risk of aortic aneurysm and dissection: nationwide cohort study

Björn Pasternak, Malin Inghammar, Henrik Svanström · BMJ · 2018 · 255 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +13